Blueshift Asset Management’s AnaptysBio ANAB Stock Holding History

Blueshift Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,852	Closed	-$381K	–	498
2025 Q4	$381K	Buy	+7,852	New	+$306K	0.11%	267

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Blueshift Asset Management's ANAB Position: Q1 2026 in Review

Blueshift Asset Management sold out of AnaptysBio (ANAB) in Q1 2026, closing a stake of 7,852 shares — an estimated $381K sold.

Blueshift Asset Management first reported a position in ANAB in Q4 2025 and held it in 1 quarter. The position peaked at $381K in Q4 2025. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

Blueshift Asset Management reported no remaining AnaptysBio position as of Q1 2026 after selling out during the quarter.
Blueshift Asset Management sold 7,852 AnaptysBio shares in Q1 2026, an estimated $381K.
Blueshift Asset Management first reported a position in AnaptysBio in Q4 2025 and held it in 1 quarter.
Blueshift Asset Management's AnaptysBio position peaked at $381K in Q4 2025.
208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Blueshift Asset Management's 13F filing for Q1 2026, filed 14 May 2026.